REGISTERED
on 24 Jan 2023
Last Applicant/ Owned by
131 Oyster Point Blvd., Suite 600
South San Francisco
CA
94080
Serial Number
90769363 filed on 11th Jun 2021
Registration Number
6965449 registered on 24th Jan 2023
Correspondent Address
LISA GREENWALD-SWIRE
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ALECTOR
Medical and pharmaceutical research and development services; providing medical and scientific research information in the field of pharmaceuticals, immuno-oncology, immuno-neurology, neurodegenerative disorders, autoimmune disorders, and gene therapy
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical and pharmaceutical research and development services; providing medical and scientific research information in the field of pharmaceuticals, immuno-oncology, immuno-neurology, neurodegenerative disorders, autoimmune disorders, and gene therapy
First Use Date in General
11th Nov 2021
First Use Date in Commerce
11th Nov 2021
Mark Details
Serial Number
No 90769363
Mark Type
No Service Mark
Attorney Docket Number
No 500860006001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.11.14 -
Three or more rectangles
26.11.21 -
Rectangles that are completely or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Jan 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th Jan 2023 | REGISTERED-PRINCIPAL REGISTER |
| 17th Dec 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 16th Dec 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 25th Nov 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 22nd Nov 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th Nov 2022 | USE AMENDMENT FILED |
| 02th Nov 2022 | TEAS STATEMENT OF USE RECEIVED |
| 07th Jun 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Apr 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |